External traditional Chinese medicine nanogel preparation for treating knee joint pain and swelling and preparation method thereof
By developing Chinese medicine nanogel preparations, using alcohol extraction, water extraction and nanoliposome technologies, combined with sodium alginate cross-linking, the deficiency of external treatment of knee pain and swelling was solved, and rapid results, high cure rate and no The effect of toxic side effects is suitable for the treatment of knee pain and swelling.
Patent Information
- Application Number
- CN202411083220.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-08
- Publication Date
- 2024-11-15
AI Technical Summary
There is a lack of effective methods for treating knee pain and swelling with external Chinese medicine in the prior art. Traditional treatment mainly relies on domestic medication or surgery, and there are few external treatments for traditional Chinese medicine, which cannot meet the needs of rapid effect, high cure rate and non-toxic side effects.
A topical Chinese medicine nanogel preparation was developed, and by selecting suitable Chinese medicine prescriptions (Verinxian, yam, podonta, angelica, safflower, angelica, angelica, angelica, licorice, sprigia, squid, squid, mint), using alcohol Extraction, water extraction, extraction and nanoliposome suspension preparation technology combines sodium alginate cross-linking to form nanogels to achieve high-efficiency drug-loading and local application of drugs.
This nanogel preparation has high-efficiency drug loading and high concentration of active ingredients, which can quickly relieve knee pain and swelling, fast effect, short course of treatment, and no toxic side effects. It is suitable for the treatment of knee meniscus injury, chronic synovitis, Clinical trials have shown that the effectiveness of cartilage injury and osteoarthritis are as high as 80%.
Smart Images

Figure CN118948753A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of traditional Chinese medicine, and in particular to an external Chinese medicine nanogel preparation for treating knee joint pain and swelling and a preparation method thereof. Background Art
[0002] With the increase of aging and sports diseases, the current treatment methods for pain and swelling around the joints such as knee meniscus injury, chronic synovitis, and knee osteoarthritis are mainly divided into conservative treatment and surgical treatment. Conservative treatment: ① Reduce the load on the knee joint by immobilizing and stabilizing the knee joint structure, such as using a knee brace or 3D plaster; ② Physical therapy promotes capillary dilation, promotes blood circulation and tissue repair, such as heat therapy, infrared, ultrasound, acupuncture, etc. ③ Oral medications for relieving pain and inflammation, such as acetaminophen and non-steroidal anti-inflammatory drugs. Surgical treatment: Common knee arthroscopy (cleaning up debris, cartilage and lesions in the joint) and joint replacement (unicompartmental or total knee replacement); the treatment plans are all aimed at relieving pain and improving joint function. Previously, the use of traditional Chinese medicine to treat knee pain and swelling usually selected Taohong Siwu Decoction for oral administration, while the use of traditional Chinese medicine for external treatment was less reported. Therefore, guided by the traditional Chinese medicine theory of external use of Chinese medicine, we select prescriptions and combine medicines through syndrome differentiation and treatment, and use the skin's absorption of Chinese medicine to improve local microcirculation to achieve the purpose of treating the disease. Summary of the invention
[0003] The technical problem to be solved by the present invention is to provide an external Chinese medicine nanogel preparation for treating knee joint pain and swelling and a preparation method thereof, aiming to effectively treat pain and swelling around the knee joint caused by diseases such as knee meniscus injury, chronic synovitis, knee cartilage injury, and knee osteoarthritis by external use of Chinese medicine, and embodies the characteristics of rapid effect, high cure rate, no toxic side effects, and easy acceptance by patients.
[0004] The technical solution of the present invention to solve the above technical problem is as follows: a method for preparing an external Chinese medicine nanogel preparation for treating knee joint pain and swelling, comprising the following steps:
[0005] S1. Selection of Chinese medicine formula: Select each Chinese medicine raw material according to the following weight parts: 10-12 parts of Clematis, 10-12 parts of Smilax glabra, 12-13 parts of Pittosporum tobira bark, 12-13 parts of Angelica sinensis, 6-8 parts of Carthamus tinctorius, 10-12 parts of Angelica dahurica, 10-12 parts of Licorice, 12-13 parts of Lycopodiella cuneata, 10-12 parts of Saposhnikovia divaricata, and 12-14 parts of Peppermint, and grind them into fine powder;
[0006] S2. Extraction and concentration of active ingredients: using fine powder as raw material, subjecting to one alcohol extraction to obtain filtrate 1 and filter residue 1, using filter residue 1 as raw material, subjecting to one water extraction to obtain filtrate 2 and filter residue 2, using filter residue 2 as raw material, subjecting to two alcohol extractions to obtain filtrate 3 and filter residue 3, using filter residue 3 as raw material, subjecting to two water extractions to obtain filtrate 4 and filter residue 4, combining filtrates 1 to 4 to obtain a drug solution, after preliminary concentration, adding ethyl acetate for extraction, and then concentrating to an extract form to obtain an extract form drug;
[0007] S3. Preparation of nanoliposome suspension: phosphatidylcholine and cholesterol are mixed in a mass ratio of 8-11:1, and then dissolved in chloroform. The chloroform is evaporated using a rotary evaporator to form a lipid film. Preheated PBS buffer is then added to fully hydrate the lipid film to form a suspension. Ultrasonic treatment is performed to make the liposomes in the suspension reach the nanoscale.
[0008] S4. Preparation of drug-loaded nanoliposome suspension: dissolving the extract drug prepared in S2 using PBS buffer, then slowly adding the dissolved drug to the nanoliposome suspension, mixing and loading the liposomes with the drug, and then removing the unencapsulated drug by dialysis or centrifugation to obtain;
[0009] S5. Formation of Chinese medicine nanogel preparations: dissolve sodium alginate powder in PBS buffer to prepare sodium alginate solution, then slowly add the drug-loaded nanoliposome suspension into the sodium alginate solution, mix thoroughly, add calcium salt aqueous solution to initiate cross-linking, form a gel after cross-linking, place the gel in a mold to shape, let it stand and solidify to form a sheet-like gel preparation, take it out and seal it for storage.
[0010] On the basis of the above technical solutions, the present invention can also make the following further specific selections or more preferred selections.
[0011] Specifically, the particle size of the fine powder in S1 is less than 150 μm, and preferably, the particle size of the fine powder is controlled to be less than 75 μm using an ultrafine grinding device.
[0012] Specifically, the first alcohol extraction in S2 refers to mixing the fine powder and alcohol at a solid-liquid ratio of 1g:20-25mL, wherein the volume concentration of the alcohol is 70-80%, soaking for 20-60min, temperature 40-70°C, ultrasonic treatment for 20-80min, ultrasonic power 50-55W, and filtering to obtain a filter residue and a filtrate; the first water extraction refers to mixing the filter residue and water at a solid-liquid ratio of 1g:50-55mL, soaking for 20-60min, temperature 90-100°C, ultrasonic treatment for 60-80min, ultrasonic power 60-65W, and filtering to obtain a filter residue. The second and filtrate two; the secondary alcohol extraction refers to mixing the filter residue two and alcohol with a volume concentration of 50-60% at a solid-liquid ratio of 1g:20-25mL, soaking for 20-60min, temperature 40-70℃, ultrasonic treatment for 20-80min, ultrasonic power 50-55W, and filtering to obtain filter residue three and filtrate three; the secondary water extraction refers to mixing the filter residue three and water at a solid-liquid ratio of 1g:50-55mL, soaking for 20-60min, temperature 90-100℃, ultrasonic treatment for 60-80min, ultrasonic power 60-65W, and filtering to obtain filter residue four and filtrate four.
[0013] Specifically, the degree of concentration of the preliminary concentration in S2 is carried out according to the ratio of 104-119g:100mL, that is, if the total weight of the Chinese medicine raw material S1 is 104-119g, the preliminary concentration should be concentrated to a liquid volume of 100mL; the volume of ethyl acetate added during extraction is 2.5-3 times the volume of the liquid.
[0014] Specifically, the dosage ratio of cholesterol to chloroform in S3 is 1-2g:50mL, the rotary evaporator draws negative pressure when rotary evaporating chloroform and controls the evaporation temperature to 40-42°C, the pH of the preheated PBS buffer is 7.4, the temperature is 45°C, the dosage ratio of lipid film to preheated PBS buffer is 10-15g:20mL, and the ultrasonic treatment of the liposome suspension refers to controlling the ultrasonic power to 50-100W and ultrasonication for 1-5min.
[0015] Specifically, the dosage ratio of the extract drug to the PBS buffer in S4 is 0.5-0.8 g:1 mL. After the extract drug and the PBS buffer are mixed, they are heated to 40-50° C. or ultrasonic treatment is used to assist dissolution. The ultrasonic power is 20-50 W and the ultrasonic time is 3-5 min.
[0016] Specifically, the dissolved drug in S4 is mixed with the nanoliposome suspension in a volume ratio of 1:9-11, and the mixing and loading of the liposome with the drug are performed by slowly stirring the mixture for 10-15 minutes.
[0017] Specifically, the sodium alginate powder in S5 is dissolved in a PBS buffer at 37° C., and the concentration of the obtained sodium alginate solution is 15-20 g / L.
[0018] Specifically, the drug-loaded nanoliposome suspension in S5 is mixed with the sodium alginate solution in a volume ratio of 1:9-11, the calcium salt aqueous solution is a calcium chloride solution with a concentration of 0.2 mol / L, and the volume ratio of the calcium salt aqueous solution to the sodium alginate solution is 1:5-6. A 7 cm × 10 cm flat rectangular silicone mold is used for shaping, and the thickness of the sheet gel preparation is 0.5-1.5 mm.
[0019] The present invention also provides an external Chinese medicine nano gel preparation for treating knee joint pain and swelling, which is prepared by the above method.
[0020] Compared with the prior art, the present invention has the following beneficial effects:
[0021] (1) The Chinese herbal medicines selected in the present invention all comply with the provisions of the Pharmacopoeia of the People's Republic of China. According to the compatibility, the present invention has the effects of dispelling wind and unblocking meridians, eliminating blood stasis and relieving pain. The external Chinese medicine nanogel preparation has a large drug loading and a high concentration of effective ingredients. It has been proven through actual use that it can effectively treat joint pain and swelling caused by diseases such as meniscus injury, chronic synovitis, cartilage injury, and osteoarthritis. It has the characteristics of quick effect and short treatment course, and is an excellent Chinese medicine for external use.
[0022] (2) The invention has a rigorous formula, is scientific and efficient, is non-toxic and harmless, has a quick effect, a short course of treatment, only needs to be applied externally, and is easily accepted by patients. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] Figure 1 It is a result chart of GO function enrichment analysis of the Chinese medicinal materials used in the present invention collected from relevant databases;
[0024] Figure 2 A result chart of KEGG pathway enrichment analysis of the Chinese medicinal materials used in the present invention collected from relevant databases;
[0025] Figure 3 The present invention provides a flowchart of a method for preparing an external Chinese medicine nanogel preparation for treating knee joint pain and swelling. DETAILED DESCRIPTION
[0026] The present invention is further described in detail below in conjunction with the accompanying drawings and specific embodiments. The examples given are only used to explain the present invention and are not used to limit the scope of the present invention.
[0027] To avoid redundant description, the Chinese medicinal materials or other raw materials used in the following examples are all commercially available products unless otherwise specified, and the methods used are all conventional methods in the art unless otherwise specified.
[0028] The basic effects of each Chinese medicinal raw material in the above Chinese medicine formula selected by the present invention are as follows:
[0029] Clematis: dispels rheumatism, dredges meridians, relieves pain, and eliminates bone sprains.
[0030] Wild Smilax glabra: detoxifies, removes dampness, and opens up joints.
[0031] Pittosporum bark: eliminates rheumatism, dredges meridians and relieves pain, kills insects and relieves itching.
[0032] Angelica: replenishes blood and promotes blood circulation, regulates menstruation and relieves pain, moisturizes the intestines and promotes bowel movements.
[0033] Safflower: promotes blood circulation, relieves menstruation, dissipates blood stasis and relieves pain.
[0034] Angelica dahurica: relieves exterior symptoms and dispels cold, dispels wind and relieves pain, clears the nasal passages, dries up dampness and stops leukorrhea, reduces swelling and discharges pus.
[0035] Licorice: nourishes the spleen and replenishes Qi, clears away heat and detoxifies, removes phlegm and relieves cough, relieves pain, and harmonizes various medicines.
[0036] Stretching grass: dispels wind and dampness, relaxes muscles and activates blood circulation.
[0037] Saposhnikovia divaricata: dispels wind and relieves exterior symptoms, eliminates dampness, relieves pain and stops convulsions.
[0038] Peppermint: Disperses wind-heat, clears the head and eyes, relieves sore throat, clears rashes, soothes the liver and promotes qi circulation.
[0039] The efficacy of the above medicines are all referenced from the tenth edition of the undergraduate textbook of the College of Traditional Chinese Medicine, "Chinese Materia Medica", published by China Traditional Chinese Medicine Press.
[0040] Analysis of drug components and targets of the above traditional Chinese medicines:
[0041] 1. Obtain information prediction of Chinese medicine components and targets
[0042] The above-mentioned traditional Chinese medicine search components and target prediction were performed in the TCMSP database. The target proteins were converted into corresponding human gene names using the Unipropt database for further analysis. After further processing of the targets obtained from each database, the key target proteins of quercetin and their corresponding human gene names were obtained, which were used as the predicted action targets of quercetin.
[0043] 2.GO functional annotation and KEGG pathway enrichment analysis
[0044] Relying on the Metascape database, a functional annotation bioinformatics analysis platform, and limiting the species to humans, GO functional enrichment analysis and KEGG pathway enrichment analysis were performed on the biological processes, molecular functions, and cellular components of the potential targets of this prescription for intervening in diseases. The resulting result files were saved and visualized for analysis in Cytoscape3.9.1 software.
[0045] 3. Results and Analysis
[0046] Based on the MetaScape database, GO functional enrichment analysis and KEGG pathway enrichment analysis were performed on 1345 intersection targets. The most relevant analysis results were visualized through the Microbiology Information Online Mapping website. The results showed that the GO functional enrichment analysis obtained the most 60 GO entries, including 20 biological process (BP) entries, including: hormone levels, inflammatory response, phosphate metabolism, inorganic response, etc.; 20 cell composition (CC) entries, including: receptor complex, membrane raft, endoplasmic reticulum cavity, cytoplasmic perinuclear region, etc.; 20 molecular function (MF) entries, including: oxidoreductase activity, transcription factor binding, neurotransmitter receptors, etc. The above selected enriched entries are displayed as follows: Figure 1 KEGG pathway enrichment analysis obtained the most 20 signaling pathways (P < 0.01), involving cancer signaling pathways, lipid and atherosclerosis signaling pathways, cGMP-PKG signaling pathways, cell senescence signaling pathways, etc. Figure 2 shown.
[0047] The specific contents of GO functional enrichment analysis are as follows:
[0048] There are 20 biological process (BP) items, including: stress response, inflammatory response, phosphate metabolism, inorganic response, etc., among which significant GO items such as "stress response" and "inflammatory response" indicate that inflammation and stress are its core pathological mechanisms. The increase of inflammatory factors such as IL-1β, TNF-α, etc. will promote the degradation of articular cartilage. Stress response includes the response of cells to various physical or chemical stresses. For example, excessive oxygen free radicals in oxidative stress response will damage articular chondrocytes and lead to cartilage degeneration; inflammation is the core pathological process of knee joint disease, involving the release of multiple inflammatory factors and the activation of immune cells. Abnormal apoptosis and proliferation of chondrocytes can lead to joint damage;
[0049] There are 20 entries in the cell composition (CC), including receptor complexes, membrane rafts, endoplasmic reticulum lumen, cytoplasmic perinuclear region, etc. Among them, the significant "mitochondria" entry indicates the importance of energy metabolism disorders in knee arthritis. Mitochondrial dysfunction can lead to reduced ATP production, affecting the metabolic activity and survival of chondrocytes; changes in the activity of signal transduction pathways in the cytoplasm directly affect the cell's response to external stimuli, such as inflammation and growth factor signals. The significance of endoplasmic reticulum-related genes reflects the stress in protein synthesis and folding, which may lead to ER stress-related apoptosis, further aggravating the pathological process of knee arthritis.
[0050] There are 20 molecular function (MF) entries, including: oxidoreductase activity, transcription factor binding, neurotransmitter receptors, etc. Among them, the significance of transporter and enzyme activity-related genes indicates the importance of these genes in maintaining the normal function of knee joint cells. Dysfunction of transporters may affect the nutritional and metabolic balance of cells, while changes in enzyme activity may affect cell signal transduction and stress response. Protein binding in binding activity involves signal transduction, enzyme regulation, etc., and changes in the binding activity of key proteins such as transcription factors and receptors. Metal ion binding, such as the binding of metal ions such as zinc and iron, these ions play an important role in enzyme activity and gene expression regulation.
[0051] Conclusion: The significance analysis of these GO terms revealed key biological processes and molecular mechanisms in knee arthritis, involving inflammatory response, oxidative stress, energy metabolism, and protein processing. These findings not only help to understand the pathogenesis of knee arthritis, but also provide potential targets for future therapeutic strategies.
[0052] The specific contents of the KEGG pathway analysis with the largest number of selected enriched genes are as follows:
[0053] VEGF signaling pathway: VEGF signals activate a series of downstream signaling pathways through VEGF receptors (such as VEGFR1 and VEGFR2), including PI3K / AKT, MAPK, PLCγ, etc. These signaling pathways promote endothelial cell proliferation, migration, and angiogenesis. In knee arthritis, overexpression of VEGF can lead to synovial angiogenesis and inflammatory response, and increase the infiltration of synovial cells and inflammatory cells. This angiogenesis and inflammatory response can lead to synovial thickening and pain. At the same time, VEGF can also increase vascular permeability, leading to joint effusion and inflammation.
[0054] Insulin signaling pathway: Insulin resistance is common in patients with obesity and metabolic syndrome, who are at increased risk of knee arthritis. Abnormal insulin signaling may lead to abnormal chondrocyte metabolism and reduced proliferation, while also increasing inflammatory responses and accelerating joint degeneration.
[0055] JAK-STAT signaling pathway: The JAK-STAT pathway is activated in knee arthritis through a variety of inflammatory factors (such as IL-6, IL-1, TNF-α), promoting inflammation and immune response. Overexpression of these factors and continuous activation of the pathway can lead to degradation of articular cartilage and continued inflammation.
[0056] cAMP signaling pathway: cAMP regulates a variety of cellular functions, including metabolism, proliferation, and differentiation, by activating protein kinase A (PKA) and other effector molecules such as EPAC. Abnormalities in cAMP signaling may lead to chondrocyte dysfunction and tissue degeneration.
[0057] FoxO signaling pathway: Activation of FoxO can increase the expression of antioxidant enzymes such as SOD and CAT, and reduce intracellular oxidative stress. Abnormal activation of the FoxO pathway may lead to increased apoptosis of chondrocytes and oxidative stress response, exacerbating joint degeneration. The FoxO pathway may also affect the degradation of cartilage matrix by regulating the expression of MMPs.
[0058] cGMP-PKG signaling pathway: cGMP regulates vascular tone, cell proliferation and apoptosis by activating PKG (protein kinase G). The cGMP-PKG pathway may affect joint health by regulating the proliferation and apoptosis of chondrocytes. Changes in cGMP levels may regulate intracellular calcium ion concentrations, affecting chondrocyte function and matrix metabolism.
[0059] Calcium signaling pathway: Abnormal calcium signaling may lead to imbalance of calcium ion levels in chondrocytes, triggering cell apoptosis and the release of matrix-degrading enzymes (such as MMPs and ADAMTS), further destroying articular cartilage. Excessive activation of calcium signaling may cause inflammatory response and cell stress, exacerbating the pathological process of knee arthritis.
[0060] Neurodegenerative disease pathways: Knee arthritis shares some mechanistic similarities with neurodegenerative diseases, especially oxidative stress and chronic inflammation. Knee chondrocytes may experience similar stress responses and protein processing disorders, leading to cell damage and joint degeneration.
[0061] Conclusion: These significant KEGG pathway analyses reveal the complex pathological mechanisms of knee arthritis, involving multiple biological processes and molecular signaling pathways, including inflammatory response, metabolic abnormalities, cell signaling, and mechanical stress. These pathways work together to lead to the degradation of knee cartilage, inflammation of the synovium, and loss of joint function. By targeting these key pathways, more effective treatments can be developed to slow down or reverse the progression of knee arthritis and improve the quality of life of patients. For example, drugs that inhibit the JAK-STAT pathway can reduce the release of inflammatory factors and relieve joint inflammation and pain; drugs that regulate the insulin signaling pathway can improve metabolic function and reduce metabolic stress and apoptosis of chondrocytes. In addition, antioxidants and anti-inflammatory drugs can protect chondrocytes and joint structures and delay the course of knee arthritis by inhibiting oxidative stress and inflammatory responses.
[0062] In one embodiment of the present invention, Figure 3 As shown, a method for preparing an external Chinese medicine nanogel preparation for treating knee joint pain and swelling is provided, comprising the following steps:
[0063] S1. Selection of Chinese medicine formula: 12g of Clematis, 12g of Smilax glabra, 12g of Pittosporum tobira bark, 12g of Angelica sinensis, 6g of Carthamus tinctorius, 12g of Angelica dahurica, 12g of Licorice, 12g of Lycopodiella cuneata, 12g of Saposhnikovia divaricata, and 12g of Mentha oleifera. Grind the selected Chinese medicine into fine powder with a particle size of less than 150μm. The above Chinese medicine formula was submitted to Lunan Pharmaceutical Group Co., Ltd. for a feasibility assessment of the filing of Chinese medicine preparations in medical institutions in June 2022 by the Affiliated Hospital of Traditional Chinese Medicine of Southwest Medical University under the name of Xianling Fumigation and Washing Recipe. The final assessment report showed that the Chinese medicine formula was significantly different in composition from the existing compound rheumatism ointment and Wengbi tablets on the market, and the formula had little similarity, so it could be filed or registered.
[0064] S2. Extraction and concentration of active ingredients: the fine powder was added into an ethanol aqueous solution (alcohol) with a volume concentration of 75% and a solid-liquid ratio of 1 g:20 mL (S:L), and the mixture was soaked for 45 min at a temperature of 60° C. and a power of 50 W for 60 min, and then filtered to obtain a residue 1 and a filtrate 1;
[0065] Add water to the filter residue 1, soak for 45 minutes under the condition of solid-liquid ratio of 1g:50mL (S:L), temperature 100°C, power 60W ultrasonic for 75 minutes, filter to obtain filter residue 2 and filtrate 2;
[0066] Add 55% ethanol aqueous solution to the residue 2, soak for 40 minutes under the conditions of solid-liquid ratio of 1g:20mL (S:L), temperature 60°C, power 50W for 50 minutes, and filter to obtain residue 3 and filtrate 3;
[0067] Add the filter residue three into water, soak for 45 minutes under the condition of a solid-liquid ratio of 1g:50mL (S:L), and perform ultrasound at a temperature of 100°C and a power of 60W for 70 minutes, and filter to obtain a filter residue four and a filtrate four; combine the filtrates one to four to obtain a medicinal solution, concentrate it to a volume of 100mL, add three times the amount of ethyl acetate for extraction, and then concentrate it to an extract to obtain an extract-like medicine for standby use.
[0068] S3. Preparation of nanoliposome suspension: phosphatidylcholine and cholesterol were mixed in a mass ratio of 10:1, wherein 2 g of cholesterol was used, and then added to 50 mL of chloroform to dissolve, and then transferred to a flask of a rotary evaporator, and the chloroform was evaporated by rotating the rotary evaporator at a mild temperature (40°C) to form a lipid film;
[0069] After the lipid film was formed in the flask, 20 mL of preheated phosphate buffered saline (PBS) buffer (pH 7.4, 45° C.) was added to the flask to fully hydrate the lipid film and form a liposome suspension.
[0070] The liposome suspension was subjected to ultrasonic treatment (ultrasonication time: 5 min, power: 60 W) to reduce the size of the liposomes to the nanometer level.
[0071] S4. Preparation of drug-loaded nanoliposome suspension: dissolve the drug extract in an appropriate amount of PBS. Heat to 45°C or use 30W ultrasonic treatment for 5 minutes to assist dissolution. Slowly add the dissolved drug to the nanoliposome suspension. The volume ratio of drug to liposome suspension is 1:10. Gently stir and mix for 15 minutes to allow the liposomes to be fully loaded with drugs. Then remove the unencapsulated drugs by dialysis or centrifugation to obtain drug-loaded nanoliposomes.
[0072] S5. Formation of Chinese medicine nanogel preparation: dissolve sodium alginate powder in PBS buffer at 37°C to prepare a 1.5% w / v sodium alginate solution, then slowly add the drug-loaded nanoliposome suspension into the sodium alginate solution at a volume ratio of 1:10, mix thoroughly, and slowly add 0.2 mol / L calcium ion solution (calcium salt aqueous solution, calcium chloride aqueous solution) to the above mixture, the volume ratio of the calcium ion solution to the sodium alginate solution is 1:5, the calcium ions in the calcium ion solution cross-link with the sodium alginate to form a gel.
[0073] Place the gel in a flat rectangular (7 cm × 10 cm) silicone mold and use a scraper to flatten the surface to ensure uniform thickness (1 mm) and avoid bubbles. Let it stand for a while to allow it to completely solidify. Remove the nanogel from the silicone mold and seal it for storage.
[0074] In addition to the above-mentioned optimal embodiment, the present invention also fine-tunes the dosage of each Chinese medicine raw material in the Chinese medicine prescription in S1 in the following other embodiments, and adaptively adjusts the corresponding process parameters in S2 to S5, and also successfully prepares an external Chinese medicine nanogel preparation for treating knee joint pain and swelling.
[0075] In one embodiment, the Chinese medicine formula is selected as follows: 10g of Clematidis, 10g of Smilax glabra, 12g of Pittosporum tobira bark, 12g of Angelica sinensis, 6g of Carthamus tinctorius, 10g of Angelica dahurica, 10g of Licorice, 12g of Lycopodiella cuneata, 10g of Saposhnikovia divaricata, and 12g of Menthus alba.
[0076] In another embodiment, the Chinese medicine formula is selected as follows: 12g of Clematidis, 12g of Smilax glabra, 13g of Pittosporum tobira bark, 13g of Angelica sinensis, 8g of Carthamus tinctorius, 12g of Angelica dahurica, 12g of Licorice, 13g of Lycopodiella cuneata, 12g of Saposhnikovia divaricata, and 14g of Menthus alba.
[0077] The external use Chinese medicine nanogel preparation prepared in the above example was used for external treatment of patients with knee joint pain and swelling. The following is a summary of the clinical trial:
[0078] Symptoms of joint diseases such as knee meniscus injury, chronic synovitis, and knee osteoarthritis include: pain around the joint, knee swelling, joint flexion and extension dysfunction, occasional snapping, cold pain, and weak legs.
[0079] Treatment:
[0080] Apply externally to the painful area, once a day, one patch each time, for 6-8 hours, and 14 days as a course of treatment.
[0081] Standard of care:
[0082] Recovery: The swelling of the knee joint has completely disappeared, and there is no other discomfort in joint movement and walking. No positive physical signs can be found in the whole body.
[0083] Improvement: The swelling and pain in the knee joint were significantly reduced, and the physical signs basically disappeared.
[0084] Ineffective; symptoms such as knee joint swelling and pain are alleviated, but joint pain worsens with more activity
[0085] Treatment results: Clinical trials have treated 150 patients with joint pain and swelling caused by meniscus injury, chronic synovitis, cartilage injury, osteoarthritis and other diseases. Among them, 90 cases were cured, accounting for 60%, 30 cases were improved, accounting for 20%, and 30 cases were ineffective, accounting for 20%. The total number of effective people was 120, and the effective rate was 80%. The clinical trial results show that it has good treatment effects and few side effects.
[0086] The treatment cases described below are only representative cases of a part of the present invention, but not all.
[0087] Case 1: Patient Yao, female, 86 years old, developed bilateral knee joint pain without obvious cause in January 2014, which worsened year by year. She was diagnosed with bilateral knee arthritis in our hospital, and the pain improved after 3 weeks of treatment with the drug of the present invention.
[0088] Case 2: Patient Xiao Moumou, female, 51 years old, developed right knee joint pain and swelling due to long-term labor in August 2023. After 2 weeks of treatment with the drug of the present invention, the swelling disappeared, the pain improved significantly, and she was able to walk normally.
[0089] Case 3: Patient Chen, male, 62 years old, developed left knee pain due to long-term labor in August 2023. After 4 weeks of treatment with the drug of the present invention, the pain was significantly improved and he was able to walk normally.
[0090] Case 4: Patient Liu, female, 48 years old, developed right knee pain after running in November 2015. After one week of treatment with the drug of the present invention, the pain basically disappeared and she was able to walk normally.
[0091] Case 5: Patient Deng, female, 28 years old, suffered from pain and swelling in the right knee joint due to a fall while dancing in August 2015. After 3 weeks of treatment with the drug of the present invention, the swelling disappeared, and after 5 weeks, the pain basically disappeared, and she was able to walk normally.
[0092] Case 6: Patient Ni, female, 51 years old, developed pain in both knees without obvious cause in August 2013, and her left knee was slightly swollen. After 2 weeks of treatment with the drug of the present invention, the swelling disappeared, the pain was significantly improved, and she was able to walk normally.
[0093] Case 7: Patient Wang, male, 48 years old, suffered from right knee pain and swelling for half a month due to a fall in January 2020. After 2 weeks of treatment with the drug of the present invention, the swelling disappeared, the pain improved significantly, and he was able to walk normally.
[0094] Case 8: Patient Xiao, male, 59 years old, developed left knee pain due to long-term labor in March 2014. After 3 weeks of treatment with the drug of the present invention, the pain basically disappeared and he was able to walk normally.
[0095] Case 9: Patient Chen, female, 40 years old, developed right knee pain after running in August 2016. After 2 weeks of treatment with the drug of the present invention, the pain basically disappeared and she was able to walk normally.
[0096] Case 10: Patient Wang, male, 37 years old, developed left knee joint pain and swelling due to long-term strain in March 2027. After 4 weeks of treatment with the drug of the present invention, the swelling disappeared, the pain improved significantly, and he was able to walk normally.
[0097] Case 11: Patient Deng Moumou, female, 76 years old, developed pain in both knees and slight swelling of the right knee due to long-term labor in August 2020. After 3 weeks of treatment with the drug of the present invention, the swelling disappeared and the pain improved significantly.
[0098] Case 12: Patient Wang, female, 65 years old, suffered from right knee pain and swelling due to a fall in August 2019. After 2 weeks of treatment with the drug of the present invention, the swelling disappeared, the pain improved significantly, and she was able to walk normally.
[0099] Case 13: Patient Chen, male, 60 years old, developed left knee pain without obvious cause in December 2013. After 1 week of treatment with the drug of the present invention, the pain basically disappeared and he was able to walk normally.
[0100] Case 14: Patient Xiao Moumou, female, 82 years old, developed pain in both knees and swelling due to long-term labor in August 2021. After 2 weeks of treatment with the drug of the present invention, the swelling basically disappeared and the pain improved significantly.
[0101] Case 15: Patient Ma Moumou, male, 71 years old, developed left knee pain and swelling due to long-term labor in May 2016. After 2 weeks of treatment with the drug of the present invention, the swelling disappeared, the pain was significantly improved, and he was able to walk normally.
[0102] In summary, the nanogel preparation provided by the present invention uses a reasonable Chinese medicine formula and a proper preparation method. The corresponding nanogel preparation product has the effects of dispelling wind and unblocking meridians, removing blood stasis and relieving pain, has a good therapeutic effect, is easy to use, economical and applicable, and is suitable for large-scale production.
[0103] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims
1. A method for preparing an external Chinese medicine nanogel preparation for treating knee joint pain and swelling, characterized in that: The steps include: S1. Selection of Chinese medicine formula: Select each Chinese medicine raw material according to the following weight parts: 10-12 parts of Clematis, 10-12 parts of Smilax glabra, 12-13 parts of Pittosporum tobira bark, 12-13 parts of Angelica sinensis, 6-8 parts of Carthamus tinctorius, 10-12 parts of Angelica dahurica, 10-12 parts of Licorice, 12-13 parts of Lycopodiella cuneata, 10-12 parts of Saposhnikovia divaricata, and 12-14 parts of Peppermint, and grind them into fine powder; S2. Extraction and concentration of active ingredients: using fine powder as raw material, subjecting to one alcohol extraction to obtain filtrate 1 and filter residue 1, using filter residue 1 as raw material, subjecting to one water extraction to obtain filtrate 2 and filter residue 2, using filter residue 2 as raw material, subjecting to two alcohol extractions to obtain filtrate 3 and filter residue 3, using filter residue 3 as raw material, subjecting to two water extractions to obtain filtrate 4 and filter residue 4, combining filtrates 1 to 4 to obtain a drug solution, after preliminary concentration, adding ethyl acetate for extraction, and then concentrating to an extract form to obtain an extract form drug; S3. Preparation of nanoliposome suspension: phosphatidylcholine and cholesterol are mixed in a mass ratio of 8-11:1, and then dissolved in chloroform. The chloroform is evaporated using a rotary evaporator to form a lipid film. Preheated PBS buffer is then added to fully hydrate the lipid film to form a suspension. Ultrasonic treatment is performed to make the liposomes in the suspension reach the nanoscale. S4. Preparation of drug-loaded nanoliposome suspension: dissolving the extract drug prepared in S2 using PBS buffer, then slowly adding the dissolved drug to the nanoliposome suspension, mixing and loading the liposomes with the drug, and then removing the unencapsulated drug by dialysis or centrifugation to obtain; S5. Formation of Chinese medicine nanogel preparations: dissolve sodium alginate powder in PBS buffer to prepare sodium alginate solution, then slowly add the drug-loaded nanoliposome suspension into the sodium alginate solution, mix thoroughly, add calcium salt aqueous solution to initiate cross-linking, form a gel after cross-linking, place the gel in a mold to shape, let it stand and solidify to form a sheet-like gel preparation, take it out and seal it for storage.
2. The method for preparing a topical Chinese medicine nanogel preparation for treating knee joint pain and swelling according to claim 1, characterized in that: The particle size of the fine powder in S1 is less than 150 μm.
3. The method for preparing the external Chinese medicine nanogel preparation for treating knee joint pain and swelling according to claim 1, characterized in that: The first alcohol extraction in S2 refers to mixing the fine powder and alcohol with a volume concentration of 70-80% at a solid-liquid ratio of 1g:20-25mL, soaking for 20-60min, temperature 40-70°C, ultrasonic treatment for 20-80min, ultrasonic power 50-55W, and filtering to obtain a filter residue 1 and a filtrate 1; the first water extraction refers to mixing the filter residue 1 and water at a solid-liquid ratio of 1g:50-55mL, soaking for 20-60min, temperature 90-100°C, ultrasonic treatment for 60-80min, ultrasonic power 60-65W, and filtering to obtain a filter residue 2 and a filtrate 2 The secondary alcohol extraction refers to mixing the filter residue II with alcohol having a volume concentration of 50-60% at a solid-liquid ratio of 1 g: 20-25 mL, soaking for 20-60 min, holding the temperature at 40-70°C, ultrasonically treating for 20-80 min, holding the ultrasonic power at 50-55 W, and filtering to obtain the filter residue III and the filtrate III; the secondary water extraction refers to mixing the filter residue III with water at a solid-liquid ratio of 1 g: 50-55 mL, soaking for 20-60 min, holding the temperature at 90-100°C, ultrasonically treating for 60-80 min, holding the ultrasonic power at 60-65 W, and filtering to obtain the filter residue IV and the filtrate IV.
4. The method for preparing the external Chinese medicine nanogel preparation for treating knee joint pain and swelling according to claim 1, characterized in that: The degree of concentration of the preliminary concentration in S2 is carried out according to the ratio of 104-119g:100mL, that is, if the total weight of the Chinese medicine raw material S1 is 104-119g, the preliminary concentration should be concentrated to a liquid volume of 100mL; the volume of ethyl acetate added during extraction is 2.5-3 times the volume of the liquid.
5. The method for preparing the external Chinese medicine nanogel preparation for treating knee joint pain and swelling according to claim 1, characterized in that: The dosage ratio of cholesterol to chloroform in S3 is 1-2g:50mL, the rotary evaporator draws negative pressure when rotary evaporating chloroform and controls the evaporation temperature to 40-42°C, the pH of the preheated PBS buffer is 7.4, the temperature is 45°C, the dosage ratio of lipid film to preheated PBS buffer is 10-15g:20mL, and the ultrasonic treatment of the liposome suspension refers to controlling the ultrasonic power to 50-100W and ultrasonication for 1-5min.
6. The method for preparing the external Chinese medicine nanogel preparation for treating knee joint pain and swelling according to claim 1, characterized in that: The dosage ratio of the extract drug to the PBS buffer in S4 is 0.5-0.8 g:1 mL. After the extract drug is mixed with the PBS buffer, it is heated to 40-50° C. or ultrasonically treated to assist dissolution. The ultrasonic power is 20-50 W and the ultrasonic time is 3-5 min.
7. The method for preparing the external Chinese medicine nanogel preparation for treating knee joint pain and swelling according to claim 6, characterized in that: The dissolved drug in S4 is mixed with the nanoliposome suspension in a volume ratio of 1:9-11. The mixing and loading of the liposome with the drug are carried out by slowly stirring the mixture for 10-15 minutes.
8. The method for preparing the external Chinese medicine nanogel preparation for treating knee joint pain and swelling according to claim 1, characterized in that: The sodium alginate powder in S5 is dissolved in PBS buffer at 37°C, and the concentration of the obtained sodium alginate solution is 15-20 g / L.
9. The method for preparing the external Chinese medicine nanogel preparation for treating knee joint pain and swelling according to claim 8, characterized in that: The drug-loaded nanoliposome suspension in S5 is mixed with the sodium alginate solution in a volume ratio of 1:9-11, the calcium salt aqueous solution is a calcium chloride solution with a concentration of 0.2 mol / L, and the volume ratio of the calcium salt aqueous solution to the sodium alginate solution is 1:5-6. A 7 cm × 10 cm flat rectangular silicone mold is used for shaping, and the thickness of the sheet gel preparation is 0.5-1.5 mm.
10. An external Chinese medicine nanogel preparation for treating knee joint pain and swelling, characterized in that: It is prepared by the method according to any one of claims 1 to 9.
